CVPath provides consultation, histology, and diagnostic services to promote discoveries that advance diagnosis and treatment of cardiovascular diseases.
Gaithersburg
Joined November 2017
- Tweets194
- Following176
- Followers270
- Likes80
Come read our latest article reviewing the spectrum of macrophage phenotypes and how they contribute to atherosclerotic plaque development and progression.
pubmed.ncbi.nlm.nih.gov/3594…
Our new publication aimed to quantify the frequency of embolic debris captured by the SENTINEL-CPS in lower-risk TAVR cases. pubmed.ncbi.nlm.nih.gov/3527…
Read our review article for a deeper understanding of sex differences and the risk factors of coronary atherosclerosis that may lead to improved outcomes of CVD in women.
Sex Differences in Coronary Atherosclerosis pubmed.ncbi.nlm.nih.gov/3517…
3
Our new publication highlighting the importance of cytokine storm-related hypercoagulation in the pathogenesis of stent thrombosis in patients with SARS-CoV-2:
Effects of Simulated COVID-19 Cytokine Storm on Stent Thrombogenicity pubmed.ncbi.nlm.nih.gov/3386…
2
Dr Kenji Kawai presents at #CRT2022 “Use of the Pulse NanoMed System to Facilitate Chronic Total Occlusion Recanalization and Reconstitution in Cadaver Limbs”
2
Dr Kenji Kawai (CVPath Fellow) presented at #CRT2022 “Acute Stent Thrombogenicity In The Transition From DAPT To SAPT In An Ex Vivo Pig Blood Flow Loop System” which was awarded best abstract
2
CVPath’s presence was prominent at #CRT2022. Dr Aloke Finn, Medical Director, presented a plethora of talks.
3
Check out the recently published article, a study led by Dr. Anne Cornelissen, in Future Cardiology, indicating the significance of COBRA PzF nanocoated coronary stents. futuremedicine.com/doi/10.22…
ALT Advancements in the development of stents have prevented stenosis in coronary arteries. Drug-eluting stents reduced in-stent restenosis and have shown better outcomes compared with bare metal stents with limitations. COBRA PzF nanocoated coronary stent has been associated with accelerated endothelialization relative to drug-eluting stents, reduced inflammation and thromboresistance in preclinical studies.
Congratulations to CVPath's Founder and President Dr. Renu Virmani who has been awarded the 11th TCTAP Award “Master of the Masters”! summit-tctap.com/2021/progra…
CVPath used an AWS-powered platform for the data in our research on cardiac injury in COVID-19 patients, discussed in more detail on the AWS Public Sector Blog. Learn more about the platform's role in our research and the conclusions that followed: aws.amazon.com/blogs/publics…
2
Featured in @JACCJournals is a recent study led by Yu Sato and Sho Torii on calcified nodules as a cause of coronary thrombosis. The full article can be found here:
sciencedirect.com/science/ar…
Additional coverage from @TCTMD following last week's publication looking at the link between myocarditis and #COVID19: tctmd.com/news/microvascular…
5
CVPath Institute Inc retweeted
great summary by @lamckeown1 @TCTMD of our recent JACC review on pathological evidence for COVID-19 induced myocarditis @CVPath_Md
The incidence of COVID-19-related myocarditis was less than 5% in this systematic review of published literature. @AlokeFinn #COVID19 #cardiopath tctmd.com/news/true-myocardi…
CVPath Institute Inc retweeted
Review Shows Little Risk for Myocarditis in COVID-19 medscape.com/viewarticle/944… via @medscape @JACCJournals
JACC Review Topic of the Week: “Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis” from CVPath’s Rika Kawakami, MD, and Atsushi Sakamoto, MD.
sciencedirect.com/science/ar…
2
Congratulations to Dr. Renu Virmani from CVPath Institute, who has recently been noted as one of the Clarivate 2020 Highly Cited Researchers for publications ranking in the top 1% by citations for field and year. #HighlyCited2020 recognition.webofscience.com…
New publication from lead authors, and former CVPath fellows, Hiroyuki Jinnouchi and Fumiyuki Otsuka: “Healthy Strut Coverage After Coronary Stent Implantation: An Ex Vivo Human Autopsy Study.”
ahajournals.org/doi/10.1161/…
2
If you missed TCT Connect 2020, here's a review on CVPath’s recently published paper from @AlokeFinn and research fellow Yu Sato. During Sunday's session, Yu presented findings on the significance of treating accessory arteries in renal denervation: tctmd.com/news/treating-acce…
CVPath Institute Inc retweeted
Interested in CVPath presentations @TCTConference?
A full list of our activities cvpath.org/find-cvpath-on-li…
Congratulations to our fellow Yu Sato for presenting his work at Late Breaking Clinical Science on Oct 18 on accessory renal nerves! Don't miss Dr. Virmani at LBCT Oct 14th!
